EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acinetobacter baumannii Bloodstream Infections: A Nationwide Study in Israel

Amir Nutman iD, Elizabeth Temkin, Liat Wullfhart, Vered Schechner, Mitchell J Schwaber, Yehuda Carmeli

Microorganisms · 29.08.2023 · 11 (9) · 2178

DOI: 10.3390/microorganisms11092178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 29.08.2023. Verfasst von Amir Nutman und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii (Ab) bloodstream infections (BSIs) are a major public health concern and associated with high mortality. We describe the nationwide incidence, antimicrobial resistance, and mortality of Ab-BSI in Israel using laboratory-based BSI surveillance data from January 2018 to December 2019. During the study period, there were 971 Ab-BSI events (508 in 2018 and 463 in 2019), with an average annual incidence of 8.08/100,000 population. The median age of patients was 72 (IQR 62–83), and 56.4% were males. Two-thirds of Ab-BSI events were hospital-onset (HO), with median day of onset 16 (IQR 9–30). HO-BSI incidence was 0.62/10,000 patient-days (rate per 10,000 patient-days: 2.78, 1.17, and 0.2 for intensive care, medical, and surgical wards, respectively). Carbapenem susceptibility was 23.4%; 41.4% and 14.9% in community and HO events, respectively. The 14-day, 30-day, and 1-year mortality were 51.2%, 59.3%, and 81.4%, respectively. Carbapenem-resistant Ab-BSI were associated with a significantly higher 14-day, 30-day, and 1-year mortality (p < 0.001 for all). In the multivariable model, age (aHR 1.02) and carbapenem resistance (aHR 3.21) were independent predictors of 30-day mortality. In conclusion, Ab-BSIs pose a significant burden with high mortality, especially associated with antimicrobial resistance. Attention should be focused on prevention and improving treatment.

Schlagwörter

Stichwörter der Autor:innen

Acinetobacter baumanniiantimicrobial resistancebloodstream infectioncarbapenem resistanceincidencemortalitypopulation-based study

Autor:innen und Institutionen

  • National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

ORCID-Profile: Amir Nutman

Zitieren

APA

Nutman, A., Temkin, E., Wullfhart, L., Schechner, V., Schwaber, M. J., & Carmeli, Y. (2023). Acinetobacter baumannii Bloodstream Infections: A Nationwide Study in Israel. Microorganisms, 11(9), 2178. https://doi.org/10.3390/microorganisms11092178

Vancouver

Nutman A, Temkin E, Wullfhart L, Schechner V, Schwaber MJ, Carmeli Y. Acinetobacter baumannii Bloodstream Infections: A Nationwide Study in Israel. Microorganisms. 2023;11(9):2178. doi:10.3390/microorganisms11092178

BibTeX
@article{Nutman2023,
  author = {Nutman, Amir and Temkin, Elizabeth and Wullfhart, Liat and Schechner, Vered and Schwaber, Mitchell J and Carmeli, Yehuda},
  title = {Acinetobacter baumannii Bloodstream Infections: A Nationwide Study in Israel},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {9},
  pages = {2178},
  doi = {10.3390/microorganisms11092178}
}
Kostenlos starten →